| Preview | Issue Date | Title | Author(s) |
| 2021 | Diagnostic yield of whole genome sequencing after non-diagnostic exome sequencing or gene panel in developmental and epileptic encephalopathies | Palmer, E.E.; Sachdev, R.; Macintosh, R.; Genetic Counselling, G.D.; Melo, U.S.; Mundlos, S.; Righetti, S.; Kandula, T.; Minoche, A.E.; Puttick, C.; Gayevskiy, V.; Hesson, L.; Idrisoglu, S.; Shoubridge, C.; Thai, M.H.N.; Davis, R.L.; Drew, A.P.; Sampaio, H.; Andrews, P.I.; Lawson, J.; et al. |
| 2016 | Genomic analyses identify molecular subtypes of pancreatic cancer | Bailey, P.; Chang, D.; Nones, K.; Johns, A.; Patch, A.; Gingras, M.; Miller, D.; Christ, A.; Bruxner, T.; Quinn, M.; Nourse, C.; Murtaugh, L.; Harliwong, I.; Idrisoglu, S.; Manning, S.; Nourbakhsh, E.; Wani, S.; Fink, L.; Holmes, O.; Chin, V.; et al. |
| 2017 | Hypermutation in pancreatic cancer | Humphris, J.L.; Patch, A.M.; Nones, K.; Bailey, P.J.; Johns, A.L.; McKay, S.; Chang, D.K.; Miller, D.K.; Pajic, M.; Kassahn, K.S.; Quinn, M.C.J.; Bruxner, T.J.C.; Christ, A.N.; Harliwong, I.; Idrisoglu, S.; Manning, S.; Nourse, C.; Nourbakhsh, E.; Stone, A.; Wilson, P.J.; et al. |
| 2013 | Somatic point mutation calling in low cellularity tumors | Kassahn, K.; Holmes, O.; Nones, K.; Patch, A.; Miller, D.; Christ, A.; Harliwong, I.; Bruxner, T.; Xu, Q.; Anderson, M.; Wood, S.; Leonard, C.; Taylor, D.; Newell, F.; Song, S.; Idrisoglu, S.; Nourse, C.; Nourbakhsh, E.; Manning, S.; Wani, S.; et al.; Jordan, I. |
| 2015 | Whole genomes redefine the mutational landscape of pancreatic cancer | Waddell, N.; Pajic, M.; Patch, A.; Chang, D.; Kassahn, K.; Bailey, P.; Johns, A.; Miller, D.; Nones, K.; Quek, K.; Quinn, M.; Robertson, A.; Fadlullah, M.; Bruxner, T.; Christ, A.; Harliwong, I.; Idrisoglu, S.; Manning, S.; Nourse, C.; Nourbakhsh, E.; et al. |
